Introduction: Management of dyslipidaemia after coronary surgery is an essential component of secondary prevention and aims to stabilise native coronary disease and maintain graft patency. Quality of lipid control is variable and multi-factorial with only a quarter of patients achieving some national lipid targets. We evaluated the influence of lipids upon conduit patency and clinical outcomes in long term follow up after primary coronary surgery, with a particular focus on defining their effects in arterial grafts.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Heart, Lung and Circulation
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2011 Published by Elsevier Inc.